Prostate Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You have been diagnosed with prostate cancer (a specific type called adenocarcinoma) that has been confirmed by a tissue sample and appears to be contained to the local area
- There is no sign that the cancer has spread to lymph nodes in the upper abdomen, bones, or other organs (some spread to lymph nodes in the lower abdomen may still be acceptable)
- You have had the recommended scans and tests to determine your cancer's stage and risk level
- You are at least 18 years old
- You are willing and able to give written consent to participate and can follow the study requirements
Who may not be able to join:
- Your prostate cancer is of a rare type called neuroendocrine or small cell carcinoma
- There is clear evidence that your cancer has spread to distant parts of the body (spread to certain nearby lymph nodes in the lower abdomen may still be considered acceptable — confirm with trial site)
- You have previously had whole-gland cryotherapy (freezing treatment), high-intensity focused ultrasound (HIFU), or brachytherapy (internal radiation seeds) on your prostate
- You have previously had radiation treatment to your pelvic area
- You have a history of Crohn's disease, ulcerative colitis, or a condition called ataxia telangiectasia
- You have another medical condition or health issue that the trial doctor believes could put you at risk or affect the reliability of the study results (confirm with trial site)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Amar Kishan, UCLA / Jonsson Comprehensive Cancer Center
Phone: 3107942971
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Incidence of acute grade ≥ 2 genitourinary (GU) toxicities
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.